Infectious Disease Testing

Increase your productivity by expanding your test menu with Capture-CMV®.

Capture-CMV

Increase your productivity by expanding your test menu with Capture-CMV^®. Designed to improve efficiencies in donor or patient testing, Capture-CMV detects IgG + IgM antibodies to cytomegalovirus in serum or plasma.

Capture-CMV can be run on the high volume NEO^® family of instruments or the semi-automated Capture^® workstation and brings the benefits of Capture Technology to your laboratory:

Ready to use reagents
Antigens are pre-coated on microwells
No special pipettes or precision pipetting
Long shelf life for better inventory management
Wash step allows for the use of slightly lipemic or hemolyzed samples

Product offerings may differ by region, please check with your local Immucor representative for regulatory status in your area.

Capture Brochure

NEO Iris Brochure

Resource Library

Our Certifications

View All Certifications

Related Products

Testimonial
Transfusion
Customer

The efficiency and reliability of the NEO^® made it possible for us to automate all type & screen samples on the NEO. With updated hardware and software features on the NEO Iris^®, making NEO even better, upgrading was an easy decision.

Raeann Thomas, Blood Bank Technical Supervisor, Hospital of the University of Pennsylvania, USA

Testimonial
Transfusion
Customer

The new camera on the Echo Lumena^® is giving us such clean, clear results! My staff will feel more comfortable when using the instrument for antibody identification due to the clear reactions.

Kevin Elman, Transfusion Services Coordinator, North Colorado Medical Center, USA

Testimonial
Transfusion
Customer

Immucor products are the only products I know that cover all advanced tests involved in transfusion medicine. Immucor instruments are stable and easy to operate.

Don-Dolcetto Ngilisho, Laboratory Services Officer, Tanzania National Blood Transfusion Service

Testimonial
Transfusion
Customer

Having the automated Echo Lumena has impacted our blood bank in many ways. It has freed up our time to accomplish other tasks while testing is running. With the Echo Lumena interfaced to our blood bank software, we were able to eliminate opportunities for clerical errors.

Lisa Knapp, MT(ASCP), Blood Bank Coordinator, Bozeman Health Deaconess Hospital

Testimonial
Transfusion
Customer

The Immucor team is helpful and knowledgeable. They are always happy to help meet customers' needs and listen to what the hospitals require.

Kerry Dowling, Blood Transfusion Laboratory Manager, Southampton General Hospital University Hospital Southampton NHS Foundation Trust, United Kingdom

Testimonial
Transfusion
Customer

Our facility has a solid organ transplant program and performs a high number of ABO titers. We were performing these titers using manual tube method, which is both time-consuming and highly dependent on using proper technique. We have many generalists rotate through the blood bank. It was difficult for us to maintain competency and consistency performing ABO titers. We have many generalists rotate through the blood bank. It was difficult for us to maintain competency and consistency performing ABO titers. Automating titers has freed up our techs to perform other tasks as well as give the physician a more accurate and reproducible result.

Alexis Crisp, MLS (ASCP) CMSBB, Blood Bank Supervisor, Avera McKennan Hospital and University Health Center

Upcoming Events,
Webinars & Workshops

View Events Calendar

Upcoming Event

Webinar: Principles of Histocompatibility Antigen Test Methods

When

April 19th 2023

Where

View

Upcoming Event

Maximum Surgical Blood Ordering Schedules: Implementation and Challenges

When

April 20th 2023

Where

Virtual

View

Upcoming Event

EFI Congress 2023

When

April 26th 2023

Where

Nantes

View

Keep Up With Us

View All News & Blogs

News & Blogs

Werfen Completes Acquisition of Immucor, Inc.

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and...

Continue Reading View All